BiLoG-Net is proposed, a deep learning framework that jointly performs breast mass segmentation and malignancy classification through bi-context location-aware feature modeling and segmentation-guided attention mechanisms, and holds strong potential for clinical computer-aided detection systems, helping radiologists prioritize suspicious cases and improve screening efficiency in busy clinical settings.
Abstract
Breast cancer remains the most commonly diagnosed malignancy among women worldwide, yet accurate detection and characterization of breast masses in mammography remain challenging due to subtle intensity variations, heterogeneous tissue densities, and indistinct lesion boundaries that complicate radiological interpretation. To address these limitations, we propose BiLoG-Net, a deep learning framework that jointly performs breast mass segmentation and malignancy classification through bi-context location-aware feature modeling and segmentation-guided attention mechanisms. Our architecture integrates a novel encoder-decoder paradigm with Fire-based feature extraction, lightweight global and local feature enhancement modules, and adaptive location-aware gating to simultaneously capture long-range contextual dependencies and fine-grained boundary-sensitive details. Unlike conventional multi-stage pipelines, our tightly coupled multi-task design enables mutual reinforcement between pixel-level localization and image-level diagnosis, reducing error propagation while producing spatially grounded malignancy predictions. Evaluated on CBIS-DDSM and INBreast benchmarks, BiLoG-Net achieves state-of-the-art performance with Dice scores of 94.20% and 93.10%, classification accuracies of 95.20% and 93.60%, and AUC values of 97.10% and 96.00%, respectively, substantially outperforming existing CNN and transformer-based baselines. By combining precise boundary delineation with reliable malignancy assessment in a single end-to-end model, this work holds strong potential for clinical computer-aided detection systems, helping radiologists prioritize suspicious cases and improve screening efficiency in busy clinical settings.
Breast cancer remains the most frequently diagnosed cancer among women worldwide and a leading cause of cancer-related death, with an estimated 2.3 million new cases and more than 670, 000 deaths worldwide in 2022. Breast ultrasonography is widely used as an adjunct diagnostic modality because it is non-ionizing, relat...
Agus Suryanto, I. G. B. Jayendra, R. Aprilianto· 2026 International Conferenc...· 0 citations
DualMiT-Net, a dual-branch network that uses both a focused view of the mass and a wider view of the surrounding tissue to provide accurate and consistent breast mass segmentation, is presented.
Alibek Kamiluly, M. Muratova, Yash Patel et al.· 0 citations
Experimental results show that the proposed hybrid network outperforms the state-of-the-art CNN-only and transformer-only models in terms of the sensitivity, specificity, and overall diagnostic accuracy, and suggest the promise of dual-stage hybrid systems for improving computer-aided diagnosis systems and assisting cl...
M. U. Ur Rahman, V. Chakravarthy, N. Sarika et al.· International journal of com...· 0 citations
Background Artificial Intelligence (AI) models for mammography classification is prone to shortcut learning because diagnostically relevant evidence is typically sparse, localized, and easily dominated by non-lesion background context. This study aimed to develop a mammography-specific framework that integrates lesion-...
Duc Quy Hoang, Van Kien Cao, Tan-Nhu Nguyen et al.· PLoS ONE· 0 citations
A graph-aware and sequence-aware deep learning framework that combines a convolutional neural network backbone for spatial feature extraction, a Graph Attention Network for lesion-structure modelling, and a Bidirectional Long Short-Term Memory (BiLSTM) module for ordered-view or slice-sequence representation learning i...
Chetanpal Singh, Santoso Wibowo, S. Grandhi et al.· Journal of Imaging· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.